The Status of Disease Registries in the United States: Reflections

Publisher： Bentham Science Publishers

ISSN： 2213-476X

Source： Applied Clinical Research, Clinical Trials and Regulatory Affairs, Vol.2, Iss.2, 2015-08, pp. : 110-112

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Disease Registries: Challenges and Opportunities to Realize Their Full Potential

By  

Applied Clinical Research, Clinical Trials and Regulatory Affairs, Vol. 2, Iss. 2, 2015-08 ,pp. : 86-89

Bentham Science Publishers

Access to resources Recommend Favorite

Cost Effectiveness of Treatment of Parkinson's Disease with Entacapone in the United States

By Palmer C.S.  

PharmacoEconomics, Vol. 20, Iss. 9, 2002-09 ,pp. : 617-628

Adis International

Access to resources Recommend Favorite

Treatment of Advanced Parkinson's Disease in the United States: A Cost-Utility Model

By Groenendaal Huybert  

Clinical Drug Investigation, Vol. 30, Iss. 11, 2010-11 ,pp. : 789-798

Adis International

Access to resources Recommend Favorite

Nine Medico-Legal Pitfalls in Inflammatory Bowel Disease in the United States

By  

Current Drug Targets, Vol. 15, Iss. 11, 2014-10 ,pp. : 1039-1041

Bentham Science Publishers

Access to resources Recommend Favorite

Disease Registries and Outcomes Research in Children: Focus on Lysosomal Storage Disorders

By Jones Simon  

Pediatric Drugs, Vol. 13, Iss. 1, 2011-02 ,pp. : 33-47

Adis International

Access to resources Recommend Favorite